Clinical significance of proliferative inflammatory atrophy in prostate biopsy;Significado clínico de la atrofia proliferativa inflamatoria en la biopsia prostática

Actas Urologicas Espanolas

Volumn 38, Issue 2, 2014, Pages 122-126

  Celma, A ^a   Servian P ^a   Planas, J ^a   Placer, J ^a   Quilez, M T ^a   Arbos M A ^a   De Torres, I ^a,b   Morote, J ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Proliferative inflammatory atrophy; Prostate cancer; Tumor aggressiveness

Indexed keywords

ATROPHY; BIOPSY; COMPLICATION; HUMAN; INFLAMMATION; MALE; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

ATROPHY; BIOPSY; HUMANS; INFLAMMATION; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84894556445     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2013.04.008     Document Type: Short Survey

References (24)

1. A. Jemal, F. Bray, and M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. O. Zaytoun, and S. Jones Prostate cancer detection after a negative prostate biopsy: Lessons learnt in the Cleveland Clinic experience Int J Urol 18 2011 557 568
3. G. Perletti, E. MonTanari, A. Vral, G. Gazzano, E. Marra, and S. Mione et al. Inflammation, prostatitis, proliferative inflammatory atrophy: «Fertile ground» for prostate cancer development? Mol Med Rep 3 2010 3 12
4. A. De Marzo, V. Marchi, J.I. Epstein, and W. Nelson Proliferative inflammatory atrophy of the prostate: Implications for prostate carcinogenesis Am J Pathol 155 1999 1985 1992
5. A. De Marzo, E. Platz, S. Sutcliffe, J. Xu, H. Grönberg, and C. Drake et al. Inflammation in prostate carcinogenesis Nat Rev Cancer 7 2007 256 269
6. G.S. Palapattu, S. Sutcliffe, P.J. Bastian, E.A. Platz, A.M. de Marzo, and W.B. Isaacs et al. Prostate carcinogenesis and inflammation: Emergin insights Carcinogenesis 26 2004 1170 1181
7. E.V. Vykhovanets, G.T. MacLennan, O.V. Vykhovanets, and S. Gupta Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients Int J Clin Exp Pathol 4 2011 552 565
8. S. Jafari, M. Etminan, and K. Afshar Nonsteroidal anti-inflammatory drugs and prostate cancer: A systematic review of the literature and meta-analysis CUAJ 3 2009 323 330
9. L.K. Dennis, C.F. Lynch, and J.C. Torner Epidemiologic association between prostatitis and prostate cancer Urology 60 2002 78 83
10. I. Cheng, J.S. Witte, S.J. Jacobsen, R. Haque, V.P. Quinn, and C.P. Quesenberry et al. Prostatitis, sexually transmitted diseases, and prostate cancer: The California Men's Health Study PLoS One 2010 15 e8736
11. A.M. De Marzo, E.A. Platz, J.I. Epstein, T. Ali, A. Billis, and T.Y. Chan et al. A Working Group Classification of focal prostate atrophy lesions Am J Surg Pathol. 30 2006 1281 1291
12. L.M. Franks Atrophy and hyperplasia in the prostate proper J Pathol Bacteriol 68 1954 617 621
13. D. Tomas, B. Kruslin, H. Rogatsch, G. Schaefer, M. Belicza, and G. Mikuz Different types of atrophy in the prostate with and without adenocarcinoma Eur Urol 51 2007 98 103
14. I. De Torres Ramírez Factores pronósticos y predictivos del carcinoma de próstata en la biopsia prostática Actas Urol Esp 31 2007 1025 1044
15. J. Woenckhaus, and I. Fenic Proliferative inflammatory atrophy: A background lesion of prostate cancer? Andrologia 40 2008 134 137
16. S. Yildiz-Sezer, I. Verdorfer, G. Schaefer, H. Rogatsch, G. Bartsch, and G. Mikuz Assessment of aberrations on chromosome 8 in prostatic atrophy Br J Urol Int 98 2006 184 188
17. R. Montironi, R. Mazzucchelli, A. Lopez-Beltran, L. Cheng, and M. Scarpelli Mechanisms of disease: High-grade prostatic intra-epithelial neoplasia and other proposed preneoplastic lesions in the prostate Nat Clin Pract Urol 4 2007 321 332
18. M. Nakayama, C.J. Bennett, J.L. Hicks, J.I. Epstein, E.A. Platz, W.G. Nelson Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpGisland is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: A detailed study using laser-capture microdissection Am J Pathol 163 2003 923 933
19. B.J. Trock, M.J. Brotzman, L.A. Mangold, B. Raghavan, and A.W. Partin Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostatebiopsies Br J Uro Int 110 2011 56 62
20. E. Maresh, V. Mah, M. Alavi, S. Horvath, L. Bagryanova, and E.S. Liebeskind et al. Differential expression of anterior gradient gene (AGR2) in prostate cancer BMC Cancer 10 2010 680
21. H. Bu, S. Bormann, G. Schäfer, W. Horninger, P. Massoner, and A. Neeb et al. The Anterior Gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection Prostate 71 2011 575 587
22. M.T. Quiles, M.A. Arbós, I.M. de Torres, C. Blazquez, J. Reventós, and J. Morote Differencial gene expresion profiling in proliferative inflammatory atrophia compared to prostate carcinoma and high grade prostatic intraneoplasia using frozen microdissected tissues Eur Urol Suppl 11 2012 e848-e848a
23. I. De Torres, M.T. Quiles, C. Blazquez, M. Arbos, A. Navarro, and S. Ramon y Cajal et al. Differential gene expression profiling in proliferative inflamatory atrophy: A comparative molecular study between PIA, HGPIN and prostate cancer Modern Pathol 25 2012 199A
24. P. Servian, A. Celma, I. Iztueta, C. Konstantinidis, J. Planas, and J. Placer et al. Proliferative inflammatory atrophy (PIA): A marker for insignificant prostate cancer? J Urol 189 4 Suppl 2013 e913